“At Apple’s Worldwide Developer Conference, an image flashed up on the screen behind VP of Software Engineering Craig Federighi. It was a screen shot from Apple’s new Health app (or a mockup thereof), showing a user’s blood glucose level,” Mark Sullivan reports for VentureBeat. “But Apple biffed the measurement for blood glucose level, as Aaron Rowe of biochemical sampling device maker Integrated Plasmonics pointed out. It’s measured in mg/dL. Apple’s slide said ‘mL/dL.'”
“Of course, this probably says nothing about the finished version of the Apple Health app we’ll see released with iOS 8 next fall. But it does raise an important issue for any company embarking on the new frontier of healthcare biosensing and informatics, no matter what form: To achieve the vision of a unified, consumer-driven health platform, they’re going to have to get the real, clinical healthcare stuff right,” Sullivan reports. “‘It will be really important for companies to justify their interpretations of the information they provide to achieve physician buy in,’ said Dr. Molly Maloof, a San Francisco Bay Area clinical physician focused on health optimization. ‘Otherwise, these consumer-focused devices will be written off as health toys rather than health tools.'”
Read more in the full article here.